Matches in SemOpenAlex for { <https://semopenalex.org/work/W2751976716> ?p ?o ?g. }
- W2751976716 endingPage "12769" @default.
- W2751976716 startingPage "12765" @default.
- W2751976716 abstract "Abstract The therapy of complex neurodegenerative diseases requires the development of multitarget‐directed drugs (MTDs). Novel indole derivatives with inhibitory activity towards acetyl/butyrylcholinesterases and monoamine oxidases A/B as well as the histamine H 3 receptor (H3R) were obtained by optimization of the neuroprotectant ASS234 by incorporating generally accepted H3R pharmacophore motifs. These small‐molecule hits demonstrated balanced activities at the targets, mostly in the nanomolar concentration range. Additional in vitro studies showed antioxidative neuroprotective effects as well as the ability to penetrate the blood–brain barrier. With this promising in vitro profile, contilisant (at 1 mg kg −1 i.p.) also significantly improved lipopolysaccharide‐induced cognitive deficits." @default.
- W2751976716 created "2017-09-15" @default.
- W2751976716 creator A5002124394 @default.
- W2751976716 creator A5011323357 @default.
- W2751976716 creator A5016614839 @default.
- W2751976716 creator A5017542552 @default.
- W2751976716 creator A5027321643 @default.
- W2751976716 creator A5029293106 @default.
- W2751976716 creator A5039672667 @default.
- W2751976716 creator A5041588106 @default.
- W2751976716 creator A5041836281 @default.
- W2751976716 creator A5044493452 @default.
- W2751976716 creator A5046358279 @default.
- W2751976716 creator A5059231449 @default.
- W2751976716 creator A5065965614 @default.
- W2751976716 creator A5071876543 @default.
- W2751976716 creator A5075420510 @default.
- W2751976716 creator A5076340354 @default.
- W2751976716 creator A5078437152 @default.
- W2751976716 creator A5081565360 @default.
- W2751976716 creator A5082905681 @default.
- W2751976716 creator A5086233448 @default.
- W2751976716 creator A5086964642 @default.
- W2751976716 date "2017-09-01" @default.
- W2751976716 modified "2023-10-18" @default.
- W2751976716 title "Multitarget‐Directed Ligands Combining Cholinesterase and Monoamine Oxidase Inhibition with Histamine H<sub>3</sub>R Antagonism for Neurodegenerative Diseases" @default.
- W2751976716 cites W1032629512 @default.
- W2751976716 cites W1756228545 @default.
- W2751976716 cites W1858523158 @default.
- W2751976716 cites W1973851363 @default.
- W2751976716 cites W1974411923 @default.
- W2751976716 cites W1980629470 @default.
- W2751976716 cites W2000336432 @default.
- W2751976716 cites W2025223727 @default.
- W2751976716 cites W2044354004 @default.
- W2751976716 cites W2048510686 @default.
- W2751976716 cites W2055300608 @default.
- W2751976716 cites W2057434602 @default.
- W2751976716 cites W2059820434 @default.
- W2751976716 cites W2069115697 @default.
- W2751976716 cites W2072219894 @default.
- W2751976716 cites W2089013306 @default.
- W2751976716 cites W2090831999 @default.
- W2751976716 cites W2091020918 @default.
- W2751976716 cites W2098568143 @default.
- W2751976716 cites W2127398647 @default.
- W2751976716 cites W2139335899 @default.
- W2751976716 cites W2140431340 @default.
- W2751976716 cites W2185348657 @default.
- W2751976716 cites W2211943037 @default.
- W2751976716 cites W2411751838 @default.
- W2751976716 cites W2464964435 @default.
- W2751976716 cites W2563388550 @default.
- W2751976716 cites W2574923937 @default.
- W2751976716 cites W4240848933 @default.
- W2751976716 doi "https://doi.org/10.1002/anie.201706072" @default.
- W2751976716 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28861918" @default.
- W2751976716 hasPublicationYear "2017" @default.
- W2751976716 type Work @default.
- W2751976716 sameAs 2751976716 @default.
- W2751976716 citedByCount "80" @default.
- W2751976716 countsByYear W27519767162018 @default.
- W2751976716 countsByYear W27519767162019 @default.
- W2751976716 countsByYear W27519767162020 @default.
- W2751976716 countsByYear W27519767162021 @default.
- W2751976716 countsByYear W27519767162022 @default.
- W2751976716 countsByYear W27519767162023 @default.
- W2751976716 crossrefType "journal-article" @default.
- W2751976716 hasAuthorship W2751976716A5002124394 @default.
- W2751976716 hasAuthorship W2751976716A5011323357 @default.
- W2751976716 hasAuthorship W2751976716A5016614839 @default.
- W2751976716 hasAuthorship W2751976716A5017542552 @default.
- W2751976716 hasAuthorship W2751976716A5027321643 @default.
- W2751976716 hasAuthorship W2751976716A5029293106 @default.
- W2751976716 hasAuthorship W2751976716A5039672667 @default.
- W2751976716 hasAuthorship W2751976716A5041588106 @default.
- W2751976716 hasAuthorship W2751976716A5041836281 @default.
- W2751976716 hasAuthorship W2751976716A5044493452 @default.
- W2751976716 hasAuthorship W2751976716A5046358279 @default.
- W2751976716 hasAuthorship W2751976716A5059231449 @default.
- W2751976716 hasAuthorship W2751976716A5065965614 @default.
- W2751976716 hasAuthorship W2751976716A5071876543 @default.
- W2751976716 hasAuthorship W2751976716A5075420510 @default.
- W2751976716 hasAuthorship W2751976716A5076340354 @default.
- W2751976716 hasAuthorship W2751976716A5078437152 @default.
- W2751976716 hasAuthorship W2751976716A5081565360 @default.
- W2751976716 hasAuthorship W2751976716A5082905681 @default.
- W2751976716 hasAuthorship W2751976716A5086233448 @default.
- W2751976716 hasAuthorship W2751976716A5086964642 @default.
- W2751976716 hasBestOaLocation W27519767162 @default.
- W2751976716 hasConcept C1122143 @default.
- W2751976716 hasConcept C170493617 @default.
- W2751976716 hasConcept C181199279 @default.
- W2751976716 hasConcept C185592680 @default.
- W2751976716 hasConcept C187714386 @default.
- W2751976716 hasConcept C202751555 @default.
- W2751976716 hasConcept C25498285 @default.
- W2751976716 hasConcept C2775864247 @default.